Reliance maps ₹1 trillion FMCG run-rate by FY30 as Karkinos clears 1 lakh HPV screenings
AGM blueprint targets doubling EBITDA in five years, with RCPL chasing ₹1 trillion in FY30 revenue and deeper bets on fresh produce, apparel and electronics retail. Healthcare arm Karkinos crosses 1 lakh HPV DNA screenings even as the stock trails 16.5% YTD.
Reliance Industries in focus after Karkinos Healthcare crossed 1 lakh HPV DNA screenings. AGM growth plans include doubling EBITDA in 5 years, ₹1 trillion FMCG target by FY30 via RCPL, and deeper push into fresh produce, apparel and electronics retail.